Taysha Gene Therapies, Inc. (TSHA)

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 2 signals for Taysha Gene Therapies, Inc.. Most notable: 2026-06-25: Filed 8-K disclosing material agreement; 2026-07-10: Nagendran Sukumar (director) sold $1.2M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Large insider sale
    Nagendran Sukumar (director) sold $1.2M of stock
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Large insider sale
    Nagendran Sukumar (director) sold $1.2M of stock
  4. Large insider sale
    Nagendran Sukumar (director) sold $1.2M of stock
  5. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-07-10Nagendran SukumardirectorS200,0006.24$1,248,000
2026-06-01Stalfort John A IIIdirectorA21,3350$0
2026-06-01Donenberg Phillip B.directorA21,3350$0
2026-06-01Long Alison SdirectorA21,3350$0
2026-06-01Sepp-Lorenzino LauradirectorA21,3350$0
2026-06-01Stalfort John A IIIdirectorA21,3350$0
2026-06-01Donenberg Phillip B.directorA21,3350$0
2026-06-01Long Alison SdirectorA21,3350$0
2026-06-01Sepp-Lorenzino LauradirectorA21,3350$0
2026-04-10Nagendran SukumardirectorS200,0004.46$892,000
2026-04-10Nagendran SukumardirectorM19,0211.71$32,526
2026-04-10Nagendran SukumardirectorM19,0211.71$32,526
2026-04-10Nagendran SukumardirectorS200,0004.46$892,000
2026-02-04Alam KamranofficerS1,6554.52$7,481
2026-02-04Alam KamranofficerS1,6554.52$7,481
2026-01-26Nagendran SukumardirectorS26,9184.61$124,092
2026-01-26Nolan Sean P.directorS41,3124.61$190,448
2026-01-26Alam KamranofficerS23,8494.61$109,944
2026-01-26Nagendran SukumardirectorS26,9184.61$124,092
2026-01-26Nolan Sean P.directorS41,3124.61$190,448
2026-01-26Alam KamranofficerS23,8494.61$109,944
2026-01-23Nagendran SukumardirectorS89,1324.75$423,377
2026-01-23Nolan Sean P.directorS136,7894.75$649,748
2026-01-23Alam KamranofficerS78,9684.75$375,098
2026-01-23Nagendran SukumardirectorS89,1324.75$423,377
2026-01-23Nolan Sean P.directorS136,7894.75$649,748
2026-01-23Alam KamranofficerS78,9684.75$375,098
2026-01-12Alam KamranofficerA359,0000$0
2026-01-12Nolan Sean P.directorA1,008,0000$0
2026-01-12Nagendran SukumardirectorM88,6761.71$151,636
2026-01-12Nagendran SukumardirectorM111,3240.7$77,927
2026-01-12Nagendran SukumardirectorS200,0004.71$942,000
2026-01-12Nagendran SukumardirectorA427,0000$0
2026-01-12Alam KamranofficerA359,0000$0
2026-01-12Nolan Sean P.directorA1,008,0000$0
2026-01-12Nagendran SukumardirectorM111,3240.7$77,804
2026-01-12Nagendran SukumardirectorM88,6761.71$151,636
2026-01-12Nagendran SukumardirectorS200,0004.71$942,000
2026-01-12Nagendran SukumardirectorA427,0000$0
2025-12-01Nagendran SukumardirectorS260,0474.51$1,172,812
2025-12-01Nagendran SukumardirectorM260,0471.71$444,680
2025-12-01Nagendran SukumardirectorM260,0471.71$444,680
2025-12-01Nagendran SukumardirectorS260,0474.51$1,172,812
2025-11-28Nagendran SukumardirectorS110,1254.75$523,094
2025-11-28Nagendran SukumardirectorM39,9531.71$68,320
2025-11-28Nagendran SukumardirectorM70,1720.7$49,120
2025-11-28Nagendran SukumardirectorM70,1720.7$49,043
2025-11-28Nagendran SukumardirectorM39,9531.71$68,320
2025-11-28Nagendran SukumardirectorS110,1254.75$523,094
2025-09-10Nagendran SukumardirectorM41,1500.7$28,805

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

Taysha Gene Therapies, Inc. (TSHA): insider trades, federal contracts, lobbying | IP Files